Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Facioscapulohumeral Muscular Dystrophy (FSHD)

Tundra lists 4 Facioscapulohumeral Muscular Dystrophy (FSHD) clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07798609

A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of SFL-0821 in adult patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-10-30

4 states

Facioscapulohumeral Muscular Dystrophy (FSHD)
COMPLETED

NCT05548556

A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

The purpose of this study is to evaluate the pharmacodynamics, safety, tolerability, pharmacokinetics, and efficacy of RO7204239, a humanized monoclonal antibody that binds to human latent myostatin, in ambulant adult participants with facioscapulohumeral muscular dystrophy (FSHD).

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-10-15

6 states

Facioscapulohumeral Muscular Dystrophy (FSHD)
NOT YET RECRUITING

NCT07872306

A Study of SAT-3247 to Evaluate the Safety, Tolerability, and Efficacy in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

This is a two-part, Phase 2, randomized, placebo-controlled, double-blind study, followed by a randomized active treatment period, to evaluate the safety and efficacy of orally administered forazapadin (SAT-3247) in adult participants with FSHD

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-13

Facioscapulohumeral Muscular Dystrophy (FSHD)
RECRUITING

NCT07409142

BetterLife FSHD: A Patient-driven Health and Research Platform

BetterLife FSHD is a registry platform built to support people living with FSHD. It connects patients with personalized resources, tools, and research opportunities that match their health experiences and needs. At the same time, BetterLife collects secure health and experience data from patients to support research. This data is shared with researchers to help better understand FSHD and work toward improved care, treatments, and outcomes for the community. Learn more and enroll at: www.BetterLifeFSHD.org

Gender: All

Ages: 1 Year - Any

Updated: 2026-02-20

1 state

FSH
FSH Muscular Dystrophy
FSHD - Facioscapulohumeral Muscular Dystrophy
+8